Puja Srivastava
Addiction Medicine · Wilmington, OHNPI 1699062257
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,727 and has fallen 93.7% since, to $235 in 2025. Among addiction medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $99.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Pharmacyclics LLC, An Abbvie Company$870
- Johnson & Johnson$614
- Alkermes, Inc.$594
- Genentech USA, Inc.$474
- Indivior Inc.$461
- plus $5K from 26 others
What the payments were for
- Travel & lodging$120%
- Food & beverage$9,22398%
- Education$1762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 11 | $1,278 |
| Pharmacyclics LLC, An Abbvie Company | 8 | $870 |
| Johnson & Johnson(2 entities) | 6 | $614 |
| Alkermes, Inc. | 8 | $594 |
| Genentech USA, Inc. | 4 | $474 |
| Indivior Inc. | 9 | $461 |
| E.r. Squibb & Sons, L.L.C. | 4 | $429 |
| Tesaro, Inc. | 3 | $371 |
| GSK | 3 | $367 |
| Bristol Myers Squibb | 3 | $349 |
| Novartis | 3 | $346 |
| Jazz Pharmaceuticals Inc. | 3 | $331 |
| Amgen | 3 | $317 |
| Daiichi Sankyo Inc. | 2 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $240 |
| Argenx US, Inc. | 2 | $238 |
| Abbott | 2 | $235 |
| Incyte Corporation | 2 | $200 |
| Medtronic | 2 | $159 |
| Seagen Inc. | 2 | $145 |
| Exelixis Inc. | 1 | $129 |
| Pfizer | 1 | $125 |
| Puma Biotechnology, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Merck | 1 | $119 |
| AVEO Pharmaceuticals, Inc. | 1 | $115 |
| Astellas Pharma US Inc | 1 | $108 |
| Beigene USA, Inc. | 1 | $103 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $91 |
| Gilead | 1 | $88 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,411 in reported general payments places this provider in the 90th percentile of 98 addiction medicine providers in Ohio.
Other addiction medicine in Wilmington
- Leslie DyeWilmington$320
- Parag PatelCincinnati$171K
- Stephanie TraylorColumbus$86K
- Wayne KawalekOakwood Village$82K
- Nicole LaborAkron$17K
- Orman HallColumbus$10K
- David KesegChillicothe$8K
- Timothy SuttonMansfield$6K
- Robert MasoneColumbus$6K
- Abdullahi MubarakCenterville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.